Septal hypertrophy

Known as: hypertrophy septal 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVES This study sought to evaluate exact release kinetics of microRNAs (miRNAs) in acute myocardial infarction (AMI… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Catheter-based treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) by alcohol ablation (transcoronary… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2004
Highly Cited
2003
Highly Cited
2003
BACKGROUND Muscle LIM protein (MLP) is an essential nuclear regulator of myogenic differentiation. Additionally, it may act as an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
The objective of this paper is to determine the frequency and outcome of asymmetrical septal hypertrophy (ASH) in large-for… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
AIMS To evaluate acute and long-term symptomatic, haemodynamic (at rest and during exercise) and electrophysiological results of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1995
Highly Cited
1995
BACKGROUND Systolic anterior motion (SAM) of the mitral valve in hypertrophic cardiomyopathy (HCM) has generally been explained… (More)
Is this relevant?
1982
1982
Clinical and morphologic features are described in a unique subgroup of seven patients with hypertrophic cardiomyopathy. Five… (More)
Is this relevant?
1980
1980
One infant with nesidioblastosis, and five of 18 infants of diabetic mothers had echocardiographically determined septal… (More)
Is this relevant?